Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sinohealth Holdings Ltd. ( (HK:2361) ) has issued an announcement.
Sinohealth Holdings has announced substantial progress in commercializing its AI large models and AI agents across multiple healthcare-related scenarios, including marketing, hospitals, pharmacies and consumer health management, marking a strategic shift from data technology services to AI-driven solutions. Its AI for Marketing Lab and “Tiangong No. 1” commercial agent now serve 182 pharmaceutical companies, while the self-developed Woodpecker Medical Model powers the iMDT consultation agent used by 512 hospitals and more than 1,520 clinicians for complex diagnoses; in parallel, specialized pharmacy and health management agents are deployed across over 10,993 pharmacies and a user base exceeding 3 million to deliver operational insights, personalized health interventions and full-cycle prevention, screening and intervention, reinforcing Sinohealth’s ambition to become the preferred AI service provider in the healthcare industry.
More about Sinohealth Holdings Ltd.
Sinohealth Holdings Limited is a Hong Kong-listed healthcare data and technology group that has evolved into an AI technology service provider. The company focuses on applying large AI models and AI agents across the healthcare value chain, offering digital intelligent solutions for pharmaceutical marketing, hospitals and clinicians, retail pharmacies, and consumer health management within an integrated “physician–pharmacy–patient” ecosystem.
Average Trading Volume: 28,775
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.21B
Learn more about 2361 stock on TipRanks’ Stock Analysis page.